New research from Emory University evaluated immune responses after the 2023–24 COVID vaccine. The study, published in Science and Translational Medicine, followed 24 participants for six months and measured memory B cells, binding antibodies, and neutralizing antibodies. The 2023–24 vaccine was monovalent and designed to match the then-dominant Omicron XBB.1.5 variant; previous vaccines had been bivalent.
Laboratory tests showed the vaccine produced antibodies with a half-life of more than 500 days, so at least half remained detectable more than 16 months after vaccination. Participants also produced cross-reactive antibodies that recognized both the ancestral WA1 strain and XBB.1.5. The researchers said immune imprinting likely contributed to a 2.8-fold increase in these cross-reactive antibodies.
The paper notes that SARS-CoV-2 has caused more than 1.2 million deaths nationwide and has many mutations. It also lists groups at higher risk of severe disease, such as people with cancer, autoimmune disorders, stroke, obesity, and existing heart, kidney, lung, or liver conditions.
Difficult words
- memory B cells — White blood cell that remembers past infections
- binding antibodies — Protein that binds to a virus or germ
- neutralizing antibodies — Antibody that can stop a virus infecting cells
- monovalent — Designed to target one strain or variant
- bivalent — Designed to target two different strains together
- half-life — Time for half of a substance to disappear
- immune imprinting — When first immune exposure shapes later responses
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Which of the risk groups named in the article would you put first for vaccine access in your community, and why?
- If antibodies remain detectable for many months, how might that change people’s plans for booster shots?
- How would you feel about a vaccine made to match a single dominant variant versus one that targets two variants? Explain briefly.
Related articles
Internet use may reduce loneliness for older unpaid caregivers
A US study found that older unpaid caregivers who use the internet more often tend to feel less lonely. Researchers analysed 2019–2020 California survey data from 3,957 caregivers aged 65 and older; about 12% had health problems.
How to Eradicate the Plague in Madagascar
Madagascar faces challenges in fighting the plague, caused by infected fleas. Experts are exploring ways to reduce infestations and prevent outbreaks.
Stay out of the emergency department this winter
Winter brings more injuries and respiratory illnesses, and emergency departments become busier. Arjun Venkatesh of Yale warned people not to walk on ice, but two days after his interview he slipped on his frozen driveway.
Mindfulness Can Strengthen Your Relationship
A study suggests that mindfulness helps couples improve their relationships and cope with stress. Practicing mindfulness can lead to greater confidence and quality in romantic partnerships.
Success of Long-Lasting HIV Drug Depends on Pricing
Healthcare experts say the availability and affordable price of lenacapavir, a new HIV prevention drug, are crucial for its success.
Cannabis and Processed Foods May Harm Heart Health
A new study shows that smoking cannabis and eating processed foods can increase heart health risks. This combination may weaken the immune system and lead to more heart problems.